3) WHO, Guidelines for Independent Lot Release of Vaccines by Regulatory Authorities, 2010.
4) T. Mizukami, et al., Application of complementary DNA microarray technology to influenza A/Vietnam/1194/2004 (H5N1) vaccine safety evaluation, Vaccine, 26, 2270-2283 (2008).
5) T. Mizukami, et al., System vaccinology for the evaluation of influenza vaccine safety by multiplex gene detection of novel biomarkers in a preclinical study and batch release test, PLoS One, 9 (7), e101835 (2014).